Pharmaceuticals roundup 2024
By 
Sarah Houlton2024-12-17T09:22:00
Diabetes and weight loss drugs have surged in popularity, revealing supply frailties
GLP-1 hormone mimicking drugs propelled Novo Nordisk and Eli Lilly to massive success this year, and are set to continue as further applications are explored. But supply chains for their manufacture were strained, requiring massive investment to meet the explosion in demand. Meanwhile vaccines have been in the spotlight with several serious viral outbreaks, and the industry is navigating legal and political challenges.